Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
314.8 INR | 0.00% | +0.25% | -20.37% |
05-22 | Indoco Remedies Gets Final Nod from US FDA for Pregabalin Capsules | MT |
05-21 | Indoco Remedies Ltd. Receives Final ANDA Approval from USFDA for Pregabalin Capsules | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.37% | 349M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.47% | 238B | |
+7.35% | 204B | |
-6.42% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- INDOCO Stock
- News Indoco Remedies Limited
- Transcript : Indoco Remedies Limited, Q3 2023 Earnings Call, Jan 24, 2023